NCT00003082View on ClinicalTrials.gov

Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

December 31, 1997

Primary Completion Date

February 28, 2001

Study Completion Date

February 28, 2001

Conditions
Chronic Myeloproliferative DisordersLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesPrecancerous/Nonmalignant ConditionUnspecified Adult Solid Tumor, Protocol Specific
Interventions
BIOLOGICAL

monoclonal antibody A27.15

BIOLOGICAL

monoclonal antibody E2.3

Trial Locations (1)

85724

Arizona Cancer Center, Tucson

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Arizona

OTHER

NCT00003082 - Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer | Biotech Hunter | Biotech Hunter